Between-group treatment effects
| Adjusted mean difference (95% CI)* | ||
| Week 12 | Week 24 | |
| V̇O2max (mL/kg/min) | 0.51 (−0.97 to 1.98) | – |
| Physical activity (min/day)† | ||
| Sedentary | −32.8 (−88.0 to 22.4) | −61.5 (−117.8 to −5.3)‡ |
| Light | −21.4 (−46.3 to 3.5) | −7.1 (−32.6 to 18.5) |
| Moderate | −2.7 (−9.2 to 3.8) | −1.7 (−8.4 to 4.9) |
| Vigorous | 0.4 (−0.7 to 1.5) | 0.0 (−1.1 to 1.1) |
| Body composition | ||
| Body mass (kg) | 0.42 (−0.74 to 1.58) | 0.12 (−1.08 to 1.32) |
| BMI (kg/m2) | 0.16 (−0.29 to 0.60) | −0.05 (−0.52 to 0.42) |
| Waist (cm) | 1.71 (0.09 to 3.34)§ | 0.17 (−1.52 to 1.86) |
| Hip (cm) | 1.16 (0.06 to 2.27)§ | −0.10 (−1.24 to 1.05) |
| Blood pressure (mm Hg) | ||
| Systolic | 3.21 (−1.89 to 8.32) | 1.06 (−4.24 to 6.37) |
| Diastolic | −1.00 (−3.88 to 1.87) | 0.04 (−2.96 to 3.03) |
| Blood lipids (mmol/L) | ||
| Total-C | 0.10 (−0.09 to 0.29) | – |
| LDL-C | 0.19 (−0.04 to 0.43) | – |
| HDL-C | 0.04 (−0.03 to 0.11) | – |
| Triglyceride | −0.06 (−0.34 to 0.22) | – |
| Blood glucose (mmol/L) | −0.21 (−0.85 to 0.42) | – |
| HRQoL | ||
| EQ-5D index | −0.03 (−0.06 to 0.01) | −0.03 (−0.06 to 0.01) |
| Health state (%) | −3.12 (−7.04 to 0.79) | −0.94 (−4.96 to 3.08) |
| Exercise motivation | ||
| Task self-efficacy (%) | 1.24 (−3.91 to 6.38) | −4.62 (−9.89 to 0.65) |
| Barrier self-efficacy (%) | −4.07 (−10.19 to 2.04) | −3.84 (−10.10 to 2.41) |
| Confidence to adhere (%) | 3.28 (−2.54 to 9.10) | −4.19 (−10.19 to 1.8) |
| Intention¶ | −0.05 (−0.36 to 0.26) | −0.27 (−0.58 to 0.05) |
| Locus of causality¶ | −0.05 (−0.47 to 0.36) | 0.18 (−0.24 to 0.60) |
| Exercise adherence (n/36) | −1.97 (−5.74 to 1.81) | – |
Statistically significant between-group differences.
↵*REMOTE-CR (intervention)-centre-based (control), adjusted for the baseline outcome, age and sex.
†Objective accelerometry.
‡Seven-point Likert scale.
§p=0.03,
¶p=0.04).
BMI, body mass index; EQ-5D, EuroQol 5-dimension; HDL-C, high-density lipoprotein cholesterol; HRQoL, health-related quality of life; LDL-C, low-density lipoprotein cholesterol; total-C, total cholesterol; V̇O2max, maximal aerobic capacity.